TAK-861: Takeda Plans to Begin Late-Stage Testing for Experimental Narcolepsy Treatment
https://pixabay.com/en/good-night-sleep-fall-asleep-1505195/

TAK-861: Takeda Plans to Begin Late-Stage Testing for Experimental Narcolepsy Treatment

In February 2024, Jacob Bell reported in Biopharma Dive that pharmaceutical company Takeda Pharmaceuticals is planning on rapidly advancing late-stage testing of TAK-861 for people with type 1 narcolepsy (also…

Continue Reading TAK-861: Takeda Plans to Begin Late-Stage Testing for Experimental Narcolepsy Treatment